(Stroke. 2000;31:2912.)
© 2000 American Heart Association, Inc.
Original Contributions |
Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Background and Purpose—When given within 3 hours of symptom onset, recombinant tissue plasminogen activator (rtPA) improves outcome 3 months after ischemic stroke. Prespecified secondary end points of the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial were CT lesion volumes in the 2 treatment groups (tPA and placebo) at 24 hours, 7 to 10 days, and 3 months after stroke.
Methods—The trial included 2 independent studies, part I and part II, with identical methods of data collection. Before part I, uniform standards were established for CT scanning. CT images were obtained at baseline, 24 hours, 7 to 10 days, and 3 months after stroke onset and were reviewed centrally by reviewers blinded to treatment group and clinical findings. Since the individual studies were not powered to test for lesion volume differences, data from both parts of the trial were combined for all analyses. The primary analysis was conducted with the use of an intention-to-treat algorithm (including patients who died or were lost to follow-up). Measured lesion volume (excluding deaths and those lost to follow-up) was used as a secondary outcome in an exploratory analysis.
Results—After tPA treatment, there was a trend toward a reduction in 3-month median lesion volume in the tPA group: 15 cm3 (interquartile range, 2 to 87) compared with 24 cm3 (interquartile range, 4 to 101) in the placebo group (P=0.06, log model) with a reduction of 11% in cumulative lesion volume, computed with Smirnov’s D statistic. After exclusion of deaths and those lost to follow-up, similar trends toward positive treatment effects were seen at all time points.
Conclusions—The direction of the effect of tPA on CT lesion volume at all time points was consistent with the observed clinical effects at 3 months. CT lesion volume may not be as sensitive a measure of treatment effect as clinical evaluation, at least as used in this study. An intention-to-treat analysis for the radiographic end point in this acute ischemic stroke clinical trial is a less biased approach to account for missing radiographic data than an analysis that uses only measured radiological data.
Key Words: cerebrovascular disorders • clinical trials • computed tomography • thrombolysis • tissue plasminogen activator
This article has been cited by other articles:
 |
|
 |
|
  K. Butcher, M. Parsons, L. Allport, S. B. Lee, P. A. Barber, B. Tress, G. A. Donnan, S. M. Davis, and for the EPITHET Investigators Rapid Assessment of Perfusion-Diffusion Mismatch Stroke, January 1, 2008; 39(1): 75 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Wu, S. Christensen, N. Hjort, R. M. Dijkhuizen, T. Kucinski, J. Fiehler, G. Thomalla, J. Rother, and L. Ostergaard Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI Brain, September 1, 2006; 129(9): 2384 - 2393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tanne, R. F. Macko, Y. Lin, B. C. Tilley, S. R. Levine, and for the NINDS rtPA Stroke Study Group Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke Stroke, July 1, 2006; 37(7): 1798 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Demchuk, M. D. Hill, P. A. Barber, B. Silver, S. C. Patel, S. R. Levine, and for the NINDS rtPA Stroke Study Group, NIH Importance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study Stroke, October 1, 2005; 36(10): 2110 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Foerch, O. C. Singer, T. Neumann-Haefelin, R. du Mesnil de Rochemont, H. Steinmetz, and M. Sitzer Evaluation of Serum S100B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery Infarction Arch Neurol, July 1, 2005; 62(7): 1130 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Saposnik, F. Webster, C. O'Callaghan, and V. Hachinski Optimizing Discharge Planning: Clinical Predictors of Longer Stay After Recombinant Tissue Plasminogen Activator for Acute Stroke Stroke, January 1, 2005; 36(1): 147 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Coutts, M. H. Lev, M. Eliasziw, L. Roccatagliata, M. D. Hill, L. H. Schwamm, J.H. W. Pexman, W. J. Koroshetz, M. E. Hudon, A. M. Buchan, et al. ASPECTS on CTA Source Images Versus Unenhanced CT: Added Value in Predicting Final Infarct Extent and Clinical Outcome Stroke, November 1, 2004; 35(11): 2472 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Mitsias, J. R. Ewing, M. Lu, M. M. Khalighi, M. Pasnoor, H. B. Ebadian, Q. Zhao, S. Santhakumar, M. A. Jacobs, N. Papamitsakis, et al. Multiparametric Iterative Self-Organizing MR Imaging Data Analysis Technique for Assessment of Tissue Viability in Acute Cerebral Ischemia AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1499 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Markus, D.C. Reutens, S. Kazui, S. Read, P. Wright, B.R. Chambers, J.I. Sachinidis, H.J. Tochon-Danguy, and G.A. Donnan Topography and Temporal Evolution of Hypoxic Viable Tissue Identified by 18F-Fluoromisonidazole Positron Emission Tomography in Humans After Ischemic Stroke Stroke, November 1, 2003; 34(11): 2646 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Hill, H. A. Rowley, F. Adler, M. Eliasziw, A. Furlan, R. T. Higashida, L. R. Wechsler, H. C. Roberts, W. P. Dillon, N. J. Fischbein, et al. Selection of Acute Ischemic Stroke Patients for Intra-Arterial Thrombolysis With Pro-Urokinase by Using ASPECTS Stroke, August 1, 2003; 34(8): 1925 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Higashida and A. J. Furlan Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke Stroke, August 1, 2003; 34 (8): e109 - e137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Foerch, R Du Mesnil de Rochemont, O Singer, T Neumann-Haefelin, M Buchkremer, F E Zanella, H Steinmetz, and M Sitzer S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion J. Neurol. Neurosurg. Psychiatry, March 1, 2003; 74(3): 322 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Mitsias, M. A. Jacobs, R. Hammoud, M. Pasnoor, S. Santhakumar, N. I.H. Papamitsakis, H. Soltanian-Zadeh, M. Lu, M. Chopp, and S. C. Patel Multiparametric MRI ISODATA Ischemic Lesion Analysis: Correlation With the Clinical Neurological Deficit and Single-Parameter MRI Techniques Stroke, December 1, 2002; 33(12): 2839 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Broderick and W. Hacke Treatment of Acute Ischemic Stroke: Part I: Recanalization Strategies Circulation, September 17, 2002; 106(12): 1563 - 1569. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bruno, S. R. Levine, M. R. Frankel, T. G. Brott, Y. Lin, B. C. Tilley, P. D. Lyden, J. P. Broderick, T. G. Kwiatkowski, and S. E. Fineberg Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial Neurology, September 10, 2002; 59(5): 669 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. van der Worp, L. J. Kappelle, A. Algra, P. R. Bar, J. M. Orgogozo, E. B. Ringelstein, P. M.W. Bath, and J. van Gijn The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke Neurology, January 8, 2002; 58(1): 133 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Patel, S. R. Levine, B. C. Tilley, J. C. Grotta, M. Lu, M. Frankel, E. C. Haley Jr, T. G. Brott, J. P. Broderick, S. Horowitz, et al. Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke JAMA, December 12, 2001; 286(22): 2830 - 2838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Morris, L. Zhang, Z. G. Zhang, M. Lu, K. L. Berens, P. M. Brown, and M. Chopp Extension of the Therapeutic Window for Recombinant Tissue Plasminogen Activator With Argatroban in a Rat Model of Embolic Stroke Stroke, November 1, 2001; 32(11): 2635 - 2640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kissela, J. Broderick, D. Woo, R. Kothari, R. Miller, J. Khoury, T. Brott, A. Pancioli, E. Jauch, J. Gebel, et al. Greater Cincinnati/Northern Kentucky Stroke Study : Volume of First-Ever Ischemic Stroke Among Blacks in a Population-Based Study Editorial Comment : The Greater Cincinnati/Northern Kentucky Stroke Study: Volume of First-Ever Ischemic Stroke Among Black Americans in a Population-Based Study Stroke, June 1, 2001; 32(6): 1285 - 1290. [Abstract] [Full Text] [PDF]
|
|